Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer
Regardless of the recent advances in therapeutic developments, cancer is still among the primary causes of death globally, indicating the need for alternative therapeutic strategies. Mitochondria, a dynamic organelle, continuously undergo the fusion and fission processes to meet cell requirements. T...
Gespeichert in:
Veröffentlicht in: | Cell biology and toxicology 2022-06, Vol.38 (3), p.377-406 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 406 |
---|---|
container_issue | 3 |
container_start_page | 377 |
container_title | Cell biology and toxicology |
container_volume | 38 |
creator | Kumar, Sanjay Ashraf, Rahail C.K., Aparna |
description | Regardless of the recent advances in therapeutic developments, cancer is still among the primary causes of death globally, indicating the need for alternative therapeutic strategies. Mitochondria, a dynamic organelle, continuously undergo the fusion and fission processes to meet cell requirements. The balanced fission and fusion processes, referred to as mitochondrial dynamics, coordinate mitochondrial shape, size, number, energy metabolism, cell cycle, mitophagy, and apoptosis. An imbalance between these opposing events alters mitochondrial dynamics, affects the overall mitochondrial shape, and deregulates mitochondrial function. Emerging evidence indicates that alteration of mitochondrial dynamics contributes to various aspects of tumorigenesis and cancer progression. Therefore, targeting the mitochondrial dynamics regulator could be a potential therapeutic approach for cancer treatment. This review will address the role of imbalanced mitochondrial dynamics in mitochondrial dysfunction during cancer progression. We will outline the clinical significance of mitochondrial dynamics regulators in various cancer types with recent updates in cancer stemness and chemoresistance and its therapeutic potential and clinical utility as a predictive biomarker.
Graphical abstract |
doi_str_mv | 10.1007/s10565-021-09662-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2583306186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2676703986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-701ed89ecee74604d1b6e24df807db9a91cbc82943adb4e5a3d83a207111356f3</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhi0Egi3wBzhUkbj0knZsxx_prUL9kkBcgKvl2BMwSuzFTpD4982yWyr1wGlkzTPvjB9Czih8pgDqS6EgpKiB0RpaKVkt9siKCsVrqRnbJytQDasZtPSIfCjlEQAkVeKQHPFGSqqZXpG7qzAl95Ciz8EOlX-JdgyuVBnv58FOKZevVRjXQ3B2CimWqk-5mh4w2zXOU3BViBPmZ4yb7vKonI0O8wk56O1Q8HRXj8ntj-83F7_qy-ufvy--XdaOKzHVCih63aJDVI2ExtNOImt8r0H5rrUtdZ3TrG249V2DwnKvuWWgKKVcyJ4fk0_b3HVOTzOWyYyhOBwGGzHNxTChOV9-reWCnv-HPqY5x-U6w6SSCnj7SrEt5XIqJWNv1jmMNr8YCmZj3Wytm8W6ebVuxDL0cRc9dyP6t5G_mheAb4GytOI95n-734n9AxoEjfs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2676703986</pqid></control><display><type>article</type><title>Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer</title><source>SpringerLink Journals - AutoHoldings</source><creator>Kumar, Sanjay ; Ashraf, Rahail ; C.K., Aparna</creator><creatorcontrib>Kumar, Sanjay ; Ashraf, Rahail ; C.K., Aparna</creatorcontrib><description>Regardless of the recent advances in therapeutic developments, cancer is still among the primary causes of death globally, indicating the need for alternative therapeutic strategies. Mitochondria, a dynamic organelle, continuously undergo the fusion and fission processes to meet cell requirements. The balanced fission and fusion processes, referred to as mitochondrial dynamics, coordinate mitochondrial shape, size, number, energy metabolism, cell cycle, mitophagy, and apoptosis. An imbalance between these opposing events alters mitochondrial dynamics, affects the overall mitochondrial shape, and deregulates mitochondrial function. Emerging evidence indicates that alteration of mitochondrial dynamics contributes to various aspects of tumorigenesis and cancer progression. Therefore, targeting the mitochondrial dynamics regulator could be a potential therapeutic approach for cancer treatment. This review will address the role of imbalanced mitochondrial dynamics in mitochondrial dysfunction during cancer progression. We will outline the clinical significance of mitochondrial dynamics regulators in various cancer types with recent updates in cancer stemness and chemoresistance and its therapeutic potential and clinical utility as a predictive biomarker.
Graphical abstract</description><identifier>ISSN: 0742-2091</identifier><identifier>EISSN: 1573-6822</identifier><identifier>DOI: 10.1007/s10565-021-09662-5</identifier><identifier>PMID: 34661828</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Apoptosis ; Biochemistry ; Biomarkers ; Biomedical and Life Sciences ; Cancer ; Cell Biology ; Cell cycle ; Cell size ; Chemoresistance ; Deregulation ; Dynamics ; Energy metabolism ; Fission ; Life Sciences ; Mitochondria ; Pharmacology/Toxicology ; Review ; Tumorigenesis</subject><ispartof>Cell biology and toxicology, 2022-06, Vol.38 (3), p.377-406</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2021. corrected publication 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature B.V.</rights><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2021. corrected publication 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-701ed89ecee74604d1b6e24df807db9a91cbc82943adb4e5a3d83a207111356f3</citedby><cites>FETCH-LOGICAL-c375t-701ed89ecee74604d1b6e24df807db9a91cbc82943adb4e5a3d83a207111356f3</cites><orcidid>0000-0001-9238-2349</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10565-021-09662-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10565-021-09662-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34661828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumar, Sanjay</creatorcontrib><creatorcontrib>Ashraf, Rahail</creatorcontrib><creatorcontrib>C.K., Aparna</creatorcontrib><title>Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer</title><title>Cell biology and toxicology</title><addtitle>Cell Biol Toxicol</addtitle><addtitle>Cell Biol Toxicol</addtitle><description>Regardless of the recent advances in therapeutic developments, cancer is still among the primary causes of death globally, indicating the need for alternative therapeutic strategies. Mitochondria, a dynamic organelle, continuously undergo the fusion and fission processes to meet cell requirements. The balanced fission and fusion processes, referred to as mitochondrial dynamics, coordinate mitochondrial shape, size, number, energy metabolism, cell cycle, mitophagy, and apoptosis. An imbalance between these opposing events alters mitochondrial dynamics, affects the overall mitochondrial shape, and deregulates mitochondrial function. Emerging evidence indicates that alteration of mitochondrial dynamics contributes to various aspects of tumorigenesis and cancer progression. Therefore, targeting the mitochondrial dynamics regulator could be a potential therapeutic approach for cancer treatment. This review will address the role of imbalanced mitochondrial dynamics in mitochondrial dysfunction during cancer progression. We will outline the clinical significance of mitochondrial dynamics regulators in various cancer types with recent updates in cancer stemness and chemoresistance and its therapeutic potential and clinical utility as a predictive biomarker.
Graphical abstract</description><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Biomarkers</subject><subject>Biomedical and Life Sciences</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cell cycle</subject><subject>Cell size</subject><subject>Chemoresistance</subject><subject>Deregulation</subject><subject>Dynamics</subject><subject>Energy metabolism</subject><subject>Fission</subject><subject>Life Sciences</subject><subject>Mitochondria</subject><subject>Pharmacology/Toxicology</subject><subject>Review</subject><subject>Tumorigenesis</subject><issn>0742-2091</issn><issn>1573-6822</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kE1P3DAQhi0Egi3wBzhUkbj0knZsxx_prUL9kkBcgKvl2BMwSuzFTpD4982yWyr1wGlkzTPvjB9Czih8pgDqS6EgpKiB0RpaKVkt9siKCsVrqRnbJytQDasZtPSIfCjlEQAkVeKQHPFGSqqZXpG7qzAl95Ciz8EOlX-JdgyuVBnv58FOKZevVRjXQ3B2CimWqk-5mh4w2zXOU3BViBPmZ4yb7vKonI0O8wk56O1Q8HRXj8ntj-83F7_qy-ufvy--XdaOKzHVCih63aJDVI2ExtNOImt8r0H5rrUtdZ3TrG249V2DwnKvuWWgKKVcyJ4fk0_b3HVOTzOWyYyhOBwGGzHNxTChOV9-reWCnv-HPqY5x-U6w6SSCnj7SrEt5XIqJWNv1jmMNr8YCmZj3Wytm8W6ebVuxDL0cRc9dyP6t5G_mheAb4GytOI95n-734n9AxoEjfs</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Kumar, Sanjay</creator><creator>Ashraf, Rahail</creator><creator>C.K., Aparna</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7TM</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PATMY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9238-2349</orcidid></search><sort><creationdate>20220601</creationdate><title>Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer</title><author>Kumar, Sanjay ; Ashraf, Rahail ; C.K., Aparna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-701ed89ecee74604d1b6e24df807db9a91cbc82943adb4e5a3d83a207111356f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Biomarkers</topic><topic>Biomedical and Life Sciences</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cell cycle</topic><topic>Cell size</topic><topic>Chemoresistance</topic><topic>Deregulation</topic><topic>Dynamics</topic><topic>Energy metabolism</topic><topic>Fission</topic><topic>Life Sciences</topic><topic>Mitochondria</topic><topic>Pharmacology/Toxicology</topic><topic>Review</topic><topic>Tumorigenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Sanjay</creatorcontrib><creatorcontrib>Ashraf, Rahail</creatorcontrib><creatorcontrib>C.K., Aparna</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cell biology and toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Sanjay</au><au>Ashraf, Rahail</au><au>C.K., Aparna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer</atitle><jtitle>Cell biology and toxicology</jtitle><stitle>Cell Biol Toxicol</stitle><addtitle>Cell Biol Toxicol</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>38</volume><issue>3</issue><spage>377</spage><epage>406</epage><pages>377-406</pages><issn>0742-2091</issn><eissn>1573-6822</eissn><abstract>Regardless of the recent advances in therapeutic developments, cancer is still among the primary causes of death globally, indicating the need for alternative therapeutic strategies. Mitochondria, a dynamic organelle, continuously undergo the fusion and fission processes to meet cell requirements. The balanced fission and fusion processes, referred to as mitochondrial dynamics, coordinate mitochondrial shape, size, number, energy metabolism, cell cycle, mitophagy, and apoptosis. An imbalance between these opposing events alters mitochondrial dynamics, affects the overall mitochondrial shape, and deregulates mitochondrial function. Emerging evidence indicates that alteration of mitochondrial dynamics contributes to various aspects of tumorigenesis and cancer progression. Therefore, targeting the mitochondrial dynamics regulator could be a potential therapeutic approach for cancer treatment. This review will address the role of imbalanced mitochondrial dynamics in mitochondrial dysfunction during cancer progression. We will outline the clinical significance of mitochondrial dynamics regulators in various cancer types with recent updates in cancer stemness and chemoresistance and its therapeutic potential and clinical utility as a predictive biomarker.
Graphical abstract</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>34661828</pmid><doi>10.1007/s10565-021-09662-5</doi><tpages>30</tpages><orcidid>https://orcid.org/0000-0001-9238-2349</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0742-2091 |
ispartof | Cell biology and toxicology, 2022-06, Vol.38 (3), p.377-406 |
issn | 0742-2091 1573-6822 |
language | eng |
recordid | cdi_proquest_miscellaneous_2583306186 |
source | SpringerLink Journals - AutoHoldings |
subjects | Apoptosis Biochemistry Biomarkers Biomedical and Life Sciences Cancer Cell Biology Cell cycle Cell size Chemoresistance Deregulation Dynamics Energy metabolism Fission Life Sciences Mitochondria Pharmacology/Toxicology Review Tumorigenesis |
title | Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A48%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20dynamics%20regulators:%20implications%20for%20therapeutic%20intervention%20in%20cancer&rft.jtitle=Cell%20biology%20and%20toxicology&rft.au=Kumar,%20Sanjay&rft.date=2022-06-01&rft.volume=38&rft.issue=3&rft.spage=377&rft.epage=406&rft.pages=377-406&rft.issn=0742-2091&rft.eissn=1573-6822&rft_id=info:doi/10.1007/s10565-021-09662-5&rft_dat=%3Cproquest_cross%3E2676703986%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2676703986&rft_id=info:pmid/34661828&rfr_iscdi=true |